Stockscreener 앱 받기
9.20
1.10%
0.10
시장 영업 전:
9.17
-0.03
-0.33%
전일 마감가:
$9.10
열려 있는:
$9.11
하루 거래량:
4.28M
Relative Volume:
0.90
시가총액:
$1.66B
수익:
$2.51B
순이익/손실:
$-171.15M
주가수익비율:
-9.5505
EPS:
-0.9633
순현금흐름:
$122.59M
1주 성능:
+16.31%
1개월 성능:
+22.02%
6개월 성능:
+30.50%
1년 성능:
+10.18%
1일 변동 폭
$8.905
$9.225
1주일 범위
$7.84
$9.225
52주 변동 폭
$4.40
$9.77
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
9.20 | 1.53B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-02-26 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-07-25 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Buy |
| 2024-09-17 | 재확인 | Jefferies | Hold |
| 2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
| 2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-06 | 재확인 | BofA Securities | Neutral |
| 2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-03 | 업그레이드 | Argus | Hold → Buy |
| 2022-02-23 | 재확인 | BofA Securities | Neutral |
| 2022-02-23 | 재확인 | Craig Hallum | Hold |
| 2022-02-23 | 재확인 | Evercore ISI | In-line |
| 2022-02-23 | 재확인 | Goldman | Buy |
| 2022-02-23 | 재확인 | JP Morgan | Overweight |
| 2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 재확인 | Needham | Buy |
| 2022-02-23 | 재확인 | Oppenheimer | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-08 | 재확인 | Piper Sandler | Overweight |
| 2021-12-02 | 재개 | Jefferies | Hold |
| 2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-28 | 재확인 | Barclays | Equal Weight |
| 2021-10-28 | 재확인 | BofA Securities | Neutral |
| 2021-10-28 | 재확인 | Canaccord Genuity | Buy |
| 2021-10-28 | 재확인 | Citigroup | Buy |
| 2021-10-28 | 재확인 | Craig Hallum | Hold |
| 2021-10-28 | 재확인 | Needham | Buy |
| 2021-10-28 | 재확인 | Oppenheimer | Outperform |
| 2021-10-28 | 재확인 | Piper Sandler | Overweight |
| 2021-10-28 | 재확인 | UBS | Neutral |
| 2021-10-19 | 개시 | Wells Fargo | Overweight |
| 2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
| 2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-22 | 개시 | Evercore ISI | In-line |
| 2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 개시 | Goldman | Neutral |
| 2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-07-13 | 개시 | Argus | Buy |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 개시 | UBS | Neutral |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
Insider Sell: Kelly Bliss Sells 2,500 Shares of Teladoc Health I - GuruFocus
Teladoc Health (NYSE: TDOC) exec sells $22,500 under 10b5-1 plan - Stock Titan
Form 144 Teladoc Health For: 1 July By Investing.com - Investing.com Canada
TDOC (NYSE) insider sale notices: 10,179 shares sold in June 2026 - Stock Titan
Teladoc Health president Kelly Bliss sells $21,250 in common stock - Investing.com UK
Teladoc Health president Kelly Bliss sells $21,250 in common stock By Investing.com - Investing.com Nigeria
Form 4 Teladoc Inc For: 30 June By Investing.com - Investing.com Nigeria
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Teladoc Health (TDOC) executive sells 2,500 shares in 10b5-1 trade - Stock Titan
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Remitly and Teladoc Shares Skyrocket, What You Need To Know - Barchart.com
Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last? - Yahoo Finance
Form 144 Teladoc Health For: 29 June By Investing.com - Investing.com Australia
Affiliate files Form 144 to sell 2,500 restricted shares (TDOC) - Stock Titan
Teladoc Health (TDOC) Faces Broad Russell Index Exit Is Its Investment Narrative Being Rewritten? - simplywall.st
Dr. Ethan Berke: Most Influential Clinical Executives 2026 - Modern Healthcare News
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Price to book forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
Enterprise value to revenue forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
Price to sales forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh - TradingView
4LL Forecast — Price Target — Prediction for 2027 - TradingView
Teladoc Health, Inc. Actuals & Estimates (NYSE:TDOC) - TradingView
Teladoc Health, Inc. Actuals & Estimates (MUN:4LL) - TradingView
Does Medicare Cover Telehealth? Yes, Here’s What to Know - GoodRx
Teladoc Health (TDOC) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Teladoc offerings are now available on Walmart’s Better Care Services - MSN
TDOCTeladoc Health Inc Latest SEC Filings - Finviz
(TDOC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Teladoc Health Inc (TDOC) Institutional Confidence - TradingKey
Teladoc Health Inc (TDOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daily Brief Health Care: Abbvie Inc, Blueprint Medicines, Cardiff Oncology, Fusion Antibodies , Guangdong True Health Medical Technology Development, High Tide , Nasos Pharma, Teladoc Health, Inc. and more - Smartkarma
Teladoc Health extends rally to seventh straight session - MSN
Primary360 from Teladoc Health Inc.virtual GP service with annual employer pricing - AD HOC NEWS
Form 13G Teladoc Health For: 22 June By Investing.com - Investing.com South Africa
Voss entities and Travis Cocke report 9.03M shares in Teladoc (TDOC) - Stock Titan
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - MarketBeat
Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider - GlobeNewswire Inc.
Teladoc: Stagnant Growth Suggests Telehealth Still A Solution Waiting For A Problem (TDOC) - Seeking Alpha
Teladoc Health (TDOC) Extends Winning Streak with 6% Gain - GuruFocus
Teladoc Health Inc (TDOC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Teladoc Health Inc (TDOC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Teladoc Health Inc (TDOC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Teladoc Health Inc (TDOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Telehealth Software Market Is Going to Boom |• Teladoc Health • Amwell • Doxy.me - openPR.com
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
0.10%
자본화:
|
볼륨(24시간):